Our Investors

To achieve our ambitious strategy to become a leading biotech company in the development of single-strain keystone biotherapies, we are open to welcome new investors.

Established in 2010, YSOPIA Bioscience has already raised €22.7M.

> Discover our pipeline

Key facts:

We are backed by renowned and valuable investors.

Seventure Partners / Health For Life Capital, Europe’s leading microbiome innovation investment fund, is our historic lead investor.

Three family offices have also backed YSOPIA Bioscience, as well as public investors, including the Nouvelle Aquitaine region. We also received support from BPI France.

Want to talk to our CEO?

Microbiome & us
Mar 4, 2021
YSOPIA Bioscience Announces the First Positive Safety Results of its CAUSALITY Study in Obesity and Associated Metabolic...
> more
Mar 4, 2021
World Obesity Day 2021 | As part of the World Obesity Day, YSOPIA would like to bring the topic of obesity to the...
> more
Press / Media
Dec 11, 2020
Ysopia Bioscience, annonce le recrutement et le traitement des premiers patients de son étude de phase 1, pour...
> more
Dec 7, 2020
La biotech Ysopia Bioscience (20 salariés) annonce le recrutement et le traitement des 38 premiers volontaires de son...
> more
Apr 22, 2020
Keystone gut bacteria are the foundation of the whole microbial ecosystem because they provide very specific metabolic...
> more
Dec 6, 2019
The term “microbiome” refers to the collection of microorganisms (or microbiota) – including bacteria, viruses and...
> more
now on twitter
YSOPIA Bioscience

📻 Have you listened to our very first podcast? As part of the World Obesity Day, we have sat down with Prof.…

YSOPIA Bioscience © 2021 - all rights reserved terms and conditions